Research study · Comprehensive Psychiatry · 2026
Blowing Minds: A cross-cultural, longitudinal investigation to unravel the highs and lows of recreational and medicinal cannabis users
Verified on PubMed Oxford CEBM Level 2B: Clinical Cohort Study
A 2026 study in Comprehensive Psychiatry tested medicinal cannabis in marijuana abuse. Protocol outlining a large-scale, cross-cultural longitudinal study examining both positive and negative effects of medicinal and recreational cannabis use. This study provides a detailed framework to understand how regular cannabis use affects mental health and cognition in real-world settings across different cultures and.
In plain language
Study overview
The Blowing Minds protocol establishes a robust framework to evaluate the complex, real-world interactions between cannabis use (medicinal vs. recreational), affect, cognition, and legal context using ecological momentary assessment. By capturing unsupervised medicinal use and granular daily variables, this study will help clinicians better understand the dual mental health outcomes associated with regular cannabis exposure.
Findings
Protocol outlining a large-scale, cross-cultural longitudinal study examining both positive and negative effects of medicinal and recreational cannabis use. Utilizes a 14-day Experience Sampling Method (ESM) coupled with baseline, 1-year, and 2-year cognitive testing and mental health assessments. Focuses on untangling how daily life factors (such as affect), product characteristics, and regional legislation shape cannabis use trajectories and CUD symptomatology.
Explore Dr. Caplan's interactive tool detailing cytochrome P450 pathways, clinical titration intervals, and physician surveillance rules.
The deeper readScientific analysis
Cannabis use is widely on the rise for recreational and medicinal purposes, with the latter often aimed at improving mental health and cognition. Simultaneously, the prevalence of cannabis-related health harms, such as cannabis use disorder (CUD), is increasing. Product potency, route of administration, and preexisting mental health symptoms play a role in the effects of cannabis; however, there is limited research on how broader factors, such as local cannabis legislation and perceptions of use, may influence these outcomes. Moreover, knowledge remains sparse regarding the growing population of medicinal users, predominantly using without medical supervision. Altogether, this illustrates the need for ecologically valid ways to investigate individuals and their cannabis usage within real-world settings. Therefore, this longitudinal, cross-cultural online study examines an international sample of regular recreational and medicinal users (aged 18-65) from different cannabis jurisdictions (e.g., the Netherlands, the United States, Brazil, Canada, and regions in Asia and Africa) in their natural environment via their mobile phone. By using the Experience Sampling Method (ESM), alongside a comprehensive battery of cognition and mental health related assessments over a 2-year period, we aim to gain insight into the short- and long-term mental health and cognitive determinants and consequences of cannabis use, and how these interact with broader, contextual factors, such as legislation. This is one of the first cross-cultural studies assessing both positive and negative effects of cannabis longitudinally, examining the full range of effects that cannabis may have on the individual.
The paper
Citation
de Bode N, Kroon E, Hsieh JH, Cousijn J Blowing Minds: A cross-cultural, longitudinal investigation to unravel the highs and lows of recreational and medicinal cannabis users. Comprehensive Psychiatry (2026). PubMed 41496191 · DOI
Limitations the authors noted
Intense ESM sampling scheme may impose burden on participants and impact compliance. Fully online study design introduces uncertainties regarding participant environment and data completion validity. Potential for participant attrition over the 2-year longitudinal follow-up period.
In practice
Why this matters
This study provides a detailed framework to understand how regular cannabis use affects mental health and cognition in real-world settings across different cultures and legal contexts. However, its complex design and long follow-up period mean it may struggle with participant dropout and data validity issues, limiting definitive conclusions about daily impacts and broader influences.
Frequently asked questions
Clinical Questions & Answers
What were the primary clinical findings regarding Marijuana use and Marijuana abuse?
Protocol outlining a large-scale, cross-cultural longitudinal study examining both positive and negative effects of medicinal and recreational cannabis use. Utilizes a 14-day Experience Sampling Method (ESM) coupled with baseline, 1-year, and 2-year cognitive testing and mental health assessments. Focuses on untangling how daily life factors (such as affect), product characteristics, and regional legislation shape cannabis use trajectories and CUD symptomatology.
What study limitations or clinical safeguards should patients keep in mind?
Intense ESM sampling scheme may impose burden on participants and impact compliance. Fully online study design introduces uncertainties regarding participant environment and data completion validity. Potential for participant attrition over the 2-year longitudinal follow-up period.
Browse related research
Condition: Marijuana abuse Topic: Marijuana use Topic: Medical cannabis
Related on CED Clinic
Back to Daily Research and Patient Questions
Reviewed by Dr. Caplan on October 27, 2026.
This page is general education about a published study. It is not medical advice and does not create a doctor-patient relationship. For care specific to you, book a consultation.
